Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K
Vaccines01:21

Vaccines

87
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
87
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of an online self-management programme for type 2 diabetes. The BEATdiabetes prospective service evaluation.

Primary care diabetesยท2025
Same author

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.

Scientific reportsยท2024
Same author

The development of an EU-wide nutrition and physical activity expert knowledge base to support a personalised mobile application across various EU population groups.

Nutrition bulletinยท2024
Same author

Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologieยท2021
Same author

Long-term changes in nutritional status and body composition in patients with malignant pancreatic disease - A systematic review.

Clinical nutrition ESPENยท2021
Same author

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.

Clinical and translational allergyยท2020

Related Experiment Video

Updated: Apr 29, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

9.6K

[Shingles vaccine: which recommendations in 2014?].

J Vionnet, K Hart, F Spertini

    Revue Medicale Suisse
    |May 20, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Zostavax, a shingles vaccine, effectively reduces incidence and complications in adults 60+. Vaccination is pharmacoeconomically viable and reduces public health burden.

    More Related Videos

    Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
    12:09

    Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

    Published on: May 2, 2011

    42.3K
    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
    08:04

    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

    Published on: July 9, 2014

    14.5K

    Related Experiment Videos

    Last Updated: Apr 29, 2026

    Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
    10:58

    Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

    Published on: August 21, 2019

    9.6K
    Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
    12:09

    Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

    Published on: May 2, 2011

    42.3K
    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
    08:04

    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

    Published on: July 9, 2014

    14.5K

    Area of Science:

    • Immunology
    • Public Health
    • Pharmacoeconomics

    Context:

    • Zostavax, a live attenuated vaccine for shingles (herpes zoster), has been available in Switzerland since 2008.
    • Evidence indicates its effectiveness in reducing shingles incidence and complications in individuals aged 60 and over.

    Purpose:

    • To evaluate the public health impact and pharmacoeconomic viability of Zostavax.
    • To determine if Switzerland should incorporate Zostavax into its national vaccination program.

    Summary:

    • The vaccine demonstrates efficacy in preventing shingles and associated complications in older adults.
    • Zostavax offers significant public health benefits by reducing illness burden.
    • The vaccine is considered pharmacoeconomically viable.

    Impact:

    • Incorporating Zostavax into the Swiss vaccination program could enhance public health outcomes for the elderly population.
    • This decision aligns with vaccination policies in the United States and other European nations.
    • The move could lead to a substantial reduction in the overall burden of shingles in Switzerland.